Zoledronate Infusion Funding
Auckland | Waitematā | Counties Manukau
Service Information
Update: From 1 July 2026 this funding has been extended across the Auckland Region as a fully funded service.
Included:
Funding of the administration of Zoledronate infusion for patients who fulfil specified criteria.
Zoledronate can be administered within the referring GP's clinic, or at a registered Infusion Centre, upon referral (see form here).
See POAC claiming schedule for funding rates
Note: Most patients can be managed with 3 infusions 18 months apart. Where bone density is very low, or the patient suffers a subsequent low-trauma/fragility fracture, the infusions may be indicated 12 monthly. Where bone density fails to improve sufficiently, additional infusions may be indicated.
Criteria
Confirm patient meets POAC funding criteria below.
Funding criteria:
Patient resident in Auckland Region or enrolled with an Auckland Region GP, AND
Patients eGFR >35, AND
Patient holds a CSC card
AND
Recommended by hospital specialist, including previous administration as an inpatient or outpatient, OR
Serious adverse reaction to Alendronate, OR
Unsuitable for use of oral medication